Cencora Inc (COR)

NYSE
Currency in USD
278.38
-4.62(-1.63%)
Closed·
Pre Market
278.78+0.40(+0.14%)
·
COR Scorecard
Full Analysis
Management has been aggressively buying back shares
Unusual trading volume
Fair Value
Day's Range
271.00278.69
52 wk Range
214.77309.35
Key Statistics
Edit
Prev. Close
278.38
Open
275.97
Day's Range
271-278.69
52 wk Range
214.77-309.35
Volume
3.77M
Average Vol. (3m)
1.87M
1-Year Change
23.94%
Book Value / Share
5.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
COR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
315.42
Upside
+13.31%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 20 consecutive years
Show more

Cencora Inc Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Cencora Inc SWOT Analysis


Financial Outlook
Analyst projections for Cencora include EPS of $15.17 for FY2025, with price targets ranging from $230 to $302, reflecting cautious optimism amid market uncertainties.
Market Challenges
Delve into Cencora's navigation of retail volatility, partnership dependencies, and potential disintermediation threats in a competitive healthcare landscape.
Acquisition Strategy
Explore how Cencora's acquisition of RCA enhances its specialty footprint, potentially accelerating growth in high-margin segments of the healthcare sector.
Specialty Dominance
Cencora's stronghold in the provider specialty market positions it as a leader in the lucrative healthcare distribution industry, driving robust financial performance.
Read full SWOT analysis

Cencora Inc Earnings Call Summary for Q2/2025

  • Cencora beats Q1 2025 expectations with EPS of $4.42 and revenue of $75.5B, stock surges 5.14% to $305.77
  • Strong performance in US Healthcare Solutions segment drives 10% revenue growth and 16% adjusted diluted EPS increase
  • Full-year EPS guidance raised to $15.70-$15.95, with 8-10% consolidated revenue growth expected
  • Company focuses on specialty medications and international expansion, anticipates rebound in clinical trial demand
  • Cencora maintains 25-year dividend streak, trades near fair value with low volatility (beta 0.6)
Last Updated: 05/07/2025, 09:53 AM
Read Full Transcript

Compare COR to Peers and Sector

Metrics to compare
COR
Peers
Sector
Relationship
P/E Ratio
31.9x18.5x−0.5x
PEG Ratio
−5.270.040.00
Price / Book
53.3x8.1x2.6x
Price / LTM Sales
0.2x2.2x2.9x
Upside (Analyst Target)
14.5%11.2%53.0%
Fair Value Upside
Unlock19.2%8.9%Unlock

Analyst Ratings

10 Buy
6 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 315.42
(+13.31% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.66%
Dividend Yield
0.78%
Industry Median 0.71%
Annualized Payout
2.20
Paid quarterly
5-Years Growth
+5.53%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
4.42 / 4.06
Revenue / Forecast
75.50B / 75.14B
EPS Revisions
Last 90 days

People Also Watch

687.52
MCK
-0.86%
175.34
BDX
+4.86%
102.87
BSX
+0.01%
363.28
HCA
+2.71%
378.75
UNH
-0.50%

FAQ

What Is the Cencora Inc (COR) Stock Price Today?

The Cencora Inc stock price today is 278.38

What Stock Exchange Does Cencora Inc Trade On?

Cencora Inc is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Cencora Inc?

The stock symbol for Cencora Inc is "COR."

Does Cencora Inc Pay Dividends? What’s The Current Dividend Yield?

The Cencora Inc dividend yield is 0.79%.

What Is the Cencora Inc Market Cap?

As of today, Cencora Inc market cap is 53.96B.

What Is Cencora Inc's Earnings Per Share (TTM)?

The Cencora Inc EPS (TTM) is 8.66.

When Is the Next Cencora Inc Earnings Date?

Cencora Inc will release its next earnings report on Jul 30, 2025.

From a Technical Analysis Perspective, Is COR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.